Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high- grade DCIS

Journal of Pathology

Volumn 187, Issue 4, 1999, Pages 403-409

  Moore, Elizabeth ^c   Magee, Hilary ^c   Coyne, John ^a   Gorey, Tom ^c   Dervan, Peter A ^b  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b MATER PRIVATE HOSPITAL   (Ireland)

^c NONE

Author keywords

Breast; CGH; Chromosomes; DCIS; In situ carcinoma

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER GRADING; CARCINOMA IN SITU; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; DNA, NEOPLASM; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 0033016778     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199903)187:4<403::AID-PATH284>3.0.CO;2-J     Document Type: Article

References (39)

1. Schwarz GF, Lagios MD, Carter D, et al. Consensus conference on the classification of ductal carcinoma in situ. Hum Pathol 1997; 28: 1221-1225.
2. Crissman JD, Visscher DW, Kubus J. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch Pathol Lab Med 1990; 114: 1249-1253.
3. Killeen JL, Namiki H. DNA analysis of ductal carcinoma in situ of the breast: a comparison with histologic features. Cancer 1991; 68: 2602-2607.
4. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995; 55: 467-471.
5. Radford DM, Fair KL, Phillips NJ, et al. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 1995; 55: 3399-3405.
6. Munn KE, Walker RA, Menasce L, Varley JM. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ. Br J Cancer 1996; 74: 1578-1585.
7. Munn KE, Walker RA, Menasce L, Varley JM. Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast. Br J Cancer 1996; 73: 636-639.
8. Munn KE, Walker RA, Varley JM. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 1995; 10: 1653-1657.
9. Yaremko ML, Kutza C, Lyzak J, Mick R, Recant WM, Westbrook CA. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer 1996; 16: 189-195.
10. Chappell SA, Walsh T, Walker RA, Shaw JA. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer 1997; 75: 1324-1329.
11. James LA, Mitchell EL, Menasce L, Varley JM. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 1997; 14: 1059-1065.
12. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 1997; 150: 297-303.
13. De PC, Schelfhout AM, Verbeeck P, et al. neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast. Hum Pathol 1995; 26: 601-606.
14. Poller DN, Silverstein MJ, Galea M, et al. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994; 7: 257-262.
15. Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Cancer 1995; 75: 2123-2131.
16. Liu E, Thor A, He M, Barcos M, Ljung BM, Benz C. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast Oncogene 1992; 7: 1027-1032.
17. Hermsen MA, Meijer GA, Baak JP, Joenje H, Walboomers JJ. Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol 1996; 27: 342-349.
18. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
19. Speicher MR, du Manoir S, Schrock E, et al. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 1993; 2: 1907-1914.
20. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994; 145: 1301-1308.
21. Lagios MD. Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 1990; 70: 853-871.
22. Pan LX, Diss TC, Peng HZ, Isaacson PG. Clonality analysis of defined B-cell populations in archival tissue sections using microdissection and the polymerase chain reaction. Histopathology 1994; 24: 323-327.
23. Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am J Pathol 1997; 150: 1465-1471.
24. Brinkschmidt C, Christiansen H, Terpe HJ, et al. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumour pathology. J Pathol 1997; 181: 394-400.
25. Piper J, Rutovitz D, Sudar D, et al. Computer image analysis of comparative genomic hybridization. Cytometry 1995; 19: 10-26.
26. du Manoir S, Schrock E, Bentz M, et al. Quantitative analysis of comparative genomic hybridization. Cytometry 1995; 19: 27-41.
27. Hui R, Campbell DH, Lee CS, et al. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997; 15: 1617-1623.
28. Theillet C, Le RX, De LO, et al. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas [published erratum appears in Oncogene 1989; 4: 1537]. Oncogene 1989; 4: 915-922.
29. Rubin H. Mutations and oncogenes - cause or effect. Nature 1984; 309: 518.
30. Nishizaki T, DeVries S, Chew K, et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997; 19: 267-272.
31. Courjal F, Theillet C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res 1997; 57: 4368-4377.
32. Nishizaki T, Chew K, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997; 74: 513-517.
33. Barlung M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer 1997; 20: 372-376.
34. Heim S, Mitelman F. Tumors of the breast. In: Anonymous Cancer Cytognetics. 2nd edn. New York: Wiley-Liss, 1995: 369-388.
35. Mitchell EL, Santibanez-Koref MF. 1p13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer. Genes Chromosomes Cancer 1990; 2: 278-289.
36. Nielsen KV, Blichert Toft M, Andersen J. Chromosome analysis of in situ breast cancer. Acta Oncol 1989; 28: 919-922.
37. Bishop JM, Weinberg RA. Scientific American Molecular Oncology. New York: Scientific American Medicine, 1996.
38. O'Malley FP, Vnencak Jones CL, Dupont WD, Parl F, Manning S. Page DL. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. Lab Invest 1994; 71: 67-72.
39. Harrison M, Magee HM, O'Loughlin J, Gorey TF, Dervan PA. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast. J Pathol 1995; 175: 303-309.